Is there an interaction between human immunodeficiency virus and Plasmodium falciparum?

International Journal of Epidemiology

Volumn 27, Issue 2, 1998, Pages 296-301

  Chandramohan, D ^a   Greenwood, B M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

HIV; Interaction; Malaria

Indexed keywords

ADOLESCENT; ADULT; AFRICA; ARTICLE; BRAIN MALARIA; CHEMOPROPHYLAXIS; CHILD; COMORBIDITY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALARIA; MEDICAL INFORMATION; MORTALITY; PARASITEMIA; PERINATAL INFECTION; PLASMODIUM FALCIPARUM; PREGNANCY; PRENATAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AFRICA; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; META-ANALYSIS; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC;

EID: 0031898956     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/27.2.296     Document Type: Article

References (46)

1. Nardin EH, Nussenzweig RS. T cell response to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu Rev Immunol 1993;11:687-727.
2. Tolle R, Fruh K, Doumbo O et al. A prospective study of the association between the human immune response to Plasmodium falciparum blood stage antigen gp 190 and control of malaria infections. Infect Immun 1993;61:40-47.
3. Al-Yaman F, Genton B, Kramer KJ et al. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity. Am J Trop Med Hyg 1996;54:443-48.
4. Egan AF, Morris J, Barnish G et al. Clinical immunity to plasmodium falciparum malaria associated with serum antibodies to the 19-kDa c-terminal fragment of merozoite surface antigen, PfMSP-1. J Infect Dis 1996;173:765-69.
5. Hogh B, Petersen E, Crandall I, Gottchau A, Sherman I. Immune responses to Band 3 neoantigens on Plasmodium falciparum-infected erythrocytes in subjects living in an area of intense malaria transmission are associated with low parasite density and high haematocrit value. Infect Immun 1994;62:4362-66.
6. Brown J, Greenwood BM, Terry RJ. Cellular mechanisms involved in recovery from acute malaria in Gambian children. Parasite Immunol 1986;8:551-64.
7. H2 cells in a rodent malaria infection. Science 1993;260:1931-34.
8. Zagury D, Bernard J, Leonard R et al. Long-term cultures of HTLV-III infected T cells: a model of cytopathology of T-cell depletion in AIDS. Science 1986;231:850-53.
9. Stanley SK, Ostrowski MA, Justement JS et al. Effect of immunization with common recall antigen of viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334:1222-30.
10. Brichacek B, Swindells S, Janoff EN, Pirrucello S, Stevenson M. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis 1996;174:1191-99.
11. Goletti D, Weissman D, Jackson RW et al. Effect of Mycobacterium tuberculosis on HIV replication. J Immunol 1996;157:1271-78.
12. Denis M, Ghadirian E. Mycobacterium avium in HIV-1 infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens. Clin Exp Immunol 1994;97:76-82.
13. Israel-Biet D, Cadrenel J, Even P. Human immunodeficiency virus production by alveolar lymphocytes is increased during pnuemocystis carini pneumonia. Am Rev Respir Dis 1993;148:1308-12.
14. Heng CY, Heng SY, Allen SG. Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus-1. Lancet 1994; 343:255-58.
15. Mcgregor IA, Rowe DS, Wilson ME, Billewicz WZ. Plasma immunoglobulin concentrations in an African (Gambian) community in relation to season, malaria and other infections and pregnancy. Clin Exp Immunol 1970;7:51-74.
16. Cohen S, Mcgregor IA, Carrington S, Synthesis of γ-globulin in Africans. Nature 1961;192:733-37.
17. Greenwood BM, Vick RM. Evidence for malaria mitogen in human malaria. Nature 1975;257:592-94.
18. Ballet JJ, Jaureguiberry G, Deloron P, Agrapart M. Stimulation of T lymphocytes-dependent differentiation of activated human B lymphocytes by Plasmodium falciparum supernatants. J Infect Dis 1987;155: 1037-40.
19. Troye-Blomberg M. Human T-cell response to blood stage antigens in Plasmodium falciparum malaria. Immunol Lett 1994;41:103-07.
20. Riley EM, Anderson G, Otoo LN, Jepsen S, Greenwood BM. Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. Clin Exp Immunol 1988;73:17-22.
21. Hviid L, Theander TG, Abdulhadi NH, Abu-zeid Y, Bayoumi RA, Jensen JB. Transient depletion of T cells with high LFA-1 expression from peripheral circulation during acute plasmodium falciparum malaria. Eur J Immunol 1991;21:1249-53.
22. Whittle HC, Brown J, Marsh K et al. T-cell control of Epstein-Barr virus-infected B cells is lost during P. falciparum malaria. Nature 1984; 312:449-50.
23. Whittle HC, Brown J, Marsk K, Blackman M, Jobe O, Shenton F. Effects of Plasmodium falciparum malaria on immune control of B lymphocytes in Gambian children. Clin Exp Immunol 1990;80: 213-18.
24. Muller O, Moser R. The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection. Trans R Soc Trop Med Hyg 1990;84:336-38.
25. Atzori C, Bruno A, Chichino G et al. HIV-1 and parasitic infections in rural Tanzania, Ann Trop Med Parasitol 1993;87:585-93.
26. Allen S, Van de Perre P, Serufilira A et al. Human immunodeficiency virus and malaria in a representative sample of childbearing women in Kigali, Rwanda. J Infect Dis 1991;164:67-71.
27. Simooya O, Mwendapole R, Siziya S, Fleming A. Relationship between falciparum malaria and HIV positivity in Ndola, Zambia. Br Med J 1988;297:30-31.
28. Muller O, Musoke P, Sen G, Moser R. Paediatric HIV-1 disease in a Kampala hospital. J Trop Pediatr 1990;36:283-86.
29. Nguyen-Dinh P, Greenberg AE, Mann JM et al. Absence of association between Plasmodium falciparum malaria and human immunodeficiency virus infection in children in Kinshasa, Zaire. Bull World Health Organ 1987;65:607-13.
30. Colebunders R, Bahwe Y, Nekwei W et al. Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. J Infect 1990;21:167-73.
31. Greenberg AE, Nsa W, Ryder RW et al. Plasmodium falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, zaire. N Engl J Med 1991;325:105-09.
32. Niyongabo T, Deloron P, Aubry P et al. Prognostic indicators in adult cerebral malaria: a study in Burundi, an area on high prevalence of HIV infection. Acta Trop 1994;56:299-305.
33. Leaver RJ, Halle Z, Watters DA et al. HIV and cerebral malaria. Trans R Soc Trop Med Hyg 1990;84:201.
34. Steketee RW, Wirima JJ, Bloland PB et al. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. Am J Trop Med Hyg 1996; 55:42-49.
35. Wabwire-Mangen F, Shift CJ, Vlahov D et al. Immunological effects of HIV-1 infection on the humoral response to malaria in an African population. Am J Trop Med Hyg 1989;41:504-11.
36. Migot F, Ouerdraogo JB, Diallo J et al. Selected P. falciparum specific immune responses are maintained in AIDS adults in Burkina Faso. Parasite Immunol 1996;18:333-39.
37. Ariyoshi K, Berry N, Wilkins D et al. A community-based study of human immunodeficiency virus type 2 provirus load in a rural village in West Africa. J Infect Dis 1996;173:245-48.
38. Gilles HM. The differential diagnosis of malaria. In: Wernsdorfer WH and McGregor I (eds). Malaria. London: Churchill Livingstone, 1988, pp.769-79.
39. Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG. Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection. AIDS 1995;9:721-26.
40. Landesman SH, Kalish LA, Burns DN et al. Obstetrical factors and the transmission of human immunodeficiency virus type-1 from mother to child. N Engl J Med 1996;334:1617-23.
41. Biggar RJ, Miotti PG, Taha ET et al. Perinatal intervention trial in Africa: effect of birth canal cleansing intervention to prevent HIV transmission. Lancet 1996;347:1647-50.
42. European collaborative study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339:1007-12.
43. Tovo PA, Martino M, Gabiano C et al. Mode of delivery and gestational age influence perinatal HIV-1 transmission. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:88-94.
44. Yamada M, Steketee R, Abramowsky C et al. Plasmodium falciparum associated with placental pathology: a light and electron microscopic and immunohistologic study. Am J Trop Med Hyg 1989;41:161-68.
45. δ cells in malaria infection. Parasitology Today 1996;12: 200-03.
46. Pape JW, Jean SS, Ho JL, Hafner A, Johnson DW Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet 1993;342:268-72.